Journal of Clinical Oncology· 2014Q1
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
- 833citations
- Q1SCImago
- 2014year
Short summary
Adding cetuximab to standard radiation and cisplatin therapy for stage III-IV head and neck cancer did not improve progression-free survival (PFS) or overall survival (OS) in a phase III trial of 891 patients.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Otorhinolaryngology
OtorhinolaryngologyMedicine